Patient 'X' has recently undergone an organ transplant and requires a specific bioactive molecule to prevent organ rejection. Patient 'Y' has been diagnosed with high blood cholesterol levels and requires a drug that acts as a competitive inhibitor for the enzyme responsible for cholesterol synthesis. Identify the specific microbes that serve as the commercial sources for the bioactive molecules administered to Patie

Step-by-step solution

Patient 'X' requires an immunosuppressive agent to prevent organ rejection. The bioactive molecule used for this purpose is Cyclosporin A, which is produced by the fungus Trichoderma polysporum. Patient 'Y' requires a blood-cholesterol lowering agent. Statins are used for this purpose, which act as competitive inhibitors for the enzyme responsible for cholesterol synthesis. Statins are produced by the yeast Monascus purpureus. Therefore, the correct microbial sources for Patient 'X' and Patient 'Y' are Trichoderma